BACE2 and type 2 diabetes mellitus: While investigating the effect of BACE2 on hIAPP fibrillation, we considered identification of this novel role for BACE2 in beta-cells and hyperamylinaemia may be controversial due to reports of BACE2 inhibition as a therapy for T2D [21, 24, 50].